← Open Payments lookup

KIMBERLY DIAZ: Open Payments

NPI 1366623639 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$688 in 42 payments from 13 companies in 2025. Trend: 2023 $722 · 2024 $926 · 2025 $688

Food & beverage: $688
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.12$164
Novo Nordisk Inc10$163
AstraZeneca Pharmaceuticals LP4$69
GlaxoSmithKline, LLC.3$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Boehringer Ingelheim Pharmaceuticals, Inc.2$34
Seqirus USA Inc2$32
Sumitomo Pharma America, Inc.2$32
Exact Sciences Corporation1$24
Azurity Pharmaceuticals, Inc.1$19

Products named: Kerendia, Ozempic, AIRSUPRA, Rybelsus, CAPLYTA, JARDIANCE, Fluad, GEMTESA.

Industry payments across TX — which companies pay providers there.